The relationship between meiotic spindle imaging and outcome of intracytoplasmic sperm injection: A retrospective study

Gynecological Endocrinology

Volumn 27, Issue 10, 2011, Pages 737-741

  Korkmaz, Cem ^a   Cinar, Ozgur ^b   Akyol, Mesut ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Etlik Zubeyde Hanim Women's Health Teaching and Research Hospital   (Turkey)

Author keywords

In vitro fertilisation; meiotic spindle; PolScope microscopy

Indexed keywords

ADULT; AGE; ARTICLE; CENTROMERE; EMBRYO; EMBRYO SCORING; FEMALE; FERTILIZATION; HUMAN; HUMAN CELL; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; MEIOSIS; MENSTRUAL CYCLE; MICROSCOPY; OOCYTE; PREDICTION; PRIORITY JOURNAL; PRONUCLEAR SCORING; SCORING SYSTEM;

ADULT; AGE FACTORS; BLASTOCYST; CELL NUCLEUS; ECTOGENESIS; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY, FEMALE; MICROINJECTIONS; MITOTIC SPINDLE APPARATUS; OOCYTES; OVULATION INDUCTION; POLAR BODIES; RETROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC; YOUNG ADULT; ZYGOTE;

EID: 80053898142     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2010.509452     Document Type: Article

References (34)

1. Wang WH, Meng L, Hackett RJ, Odenbourg R, Keefe DL. The spindle observation and its relationship with fertilization after intracytoplasmic sperm injection in living human oocytes. Fertil Steril 2001;75:348-353.
2. Wang WH, Keefe DL. Prediction of chromosome misalignment among in vitro matured human oocytes by spindle imaging with the PolScope. Fertil Steril 2002;78:1077-1081.
3. Can A, Semiz O, Cinar O. Bisphenol-A induces cell cycledelay and alters centrosome and spindle microtubular organization in oocytes during meiosis. Mol Hum Reprod 2005;11:389-396.
4. Silva CP, Kommineni K, Oldenbourg R, Keefe DL. The first polar body does not predict accurately the location of the metaphase II meiotic spindle in mammalian oocytes. Fertil Steril 1999;71:719-721.
5. Avery S, Blayney M. Effect of the position of the meiotic spindle on the outcome of intracytoplasmic sperm injection. Hum Fertil (Camb) 2003;6:19-22.
6. Mattsson LA, Cullberg G, Hamberger L, Samsioe G, Silfverstolpe G. Lipid metabolism in women with polycystic ovary syndrome: possible implications for an increased risk of coronary heart disease. Fertil Steril 1984;42:579-584
7. Diamanti-Kandarakis E, Papavassiliou AG, Stylianos A, Kandarakis AS, Chrousos GP. Pathophysiology and types of dyslipidemia in PCOS. Trends Mol Endocrinol 2007;18:208-215
8. Holte J, Bergh T, Berne C, Lithell H. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables. Clin Endocrinol (Oxf) 1994;41:463-471
9. Cibula D, Cífková R, Fanta M, Poledne R, Zivny J, Skibová J. Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome. Hum Reprod 2000;15:785-789
10. Legro RS, Blanche P, Krauss RM, Lobo RA. Alterations in low-density lipoprotein and high-density lipoprotein subclasses among Hispanic women with polycystic ovary syndrome: influence of insulin and genetic factors. Fertil Steril 1999;72:990-995
11. Legro RS, Kunselman MA, Dunaif A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 2001;111:607-613
12. Pirwany IR, Fleming R, Greer IA, Packard CJ, Sattar N. Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters. Clin Endocrinol (Oxf) 2001;54:447-453
13. Marcondes JAM, Hayashida SAY, Barcellos CRG, Rocha MP, Maciel GAR, Baracat EC. Metabolic syndrome in women with polycystic ovary syndrome: prevalence, characteristics and predictors. Arq Bras Endocrinol Metab 2007; 51:972-979
14. Carmina E, Legro RS, Stamets K, Lowell J, Lobo RA. Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet. Hum Reprod 2003;18:2289-2293
15. Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, editors. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications; 1992 pp 377-384
16. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-47
17. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006;91:37-45
18. Ferriman D, Galwey G. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440-1447
19. Third report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (AdultTreatment Panel III) final report. Circulation 2002;106:3143-3421
20. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of preparative ultracentrifuge. Clin Chem 1972;18:499-502
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-19
22. Dean JA, Coulombier D, Brendel KA, Smith DC, Burton AH, Dicker RC, Sullivan K, Fagan RF, Arner TB. Epi Info 2000, a database and statistical program for public health professionals for use on Windows 95, 98, NT, and 2000 computers. Atlanta, Georgia, USA: Center for Disease Control and Prevention; 2000
23. Wild RA, Painter PC, Coulson PB, Carruth BK, Ranney GB. Lipoprotein lipid concentration and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1985;61:946-951
24. Strowitzki T, Halser B, Demant T. Body fat distribution, insulin sensitivity, ovarian dysfunction and serum lipoproteins in patients with polycystic ovary syndrome. Gynecol Endocrinol 2002;16:45-51
25. Slowinska-Srzednicka J, Zgliczynski S, Wierzbicki M, Srzednicki M, Stopinska-Gluszak U, Zgliczynski W, Soszyński P, Chotkowska E, Bednarska M, Sadowski Z. The role of hyperinsulinemia in development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome. J Endocrinol Invest 1991;14:569-575
26. Yilmaz M, Biri A, Bukan N, Karakoc A, Sancak B, Toruner F, Pasaoglu H. Levels of lipoprotein and homocysteine in nonobese and obese patients with polycystic ovary syndrome. Gynecol Endocrinol 2005;20:258-263
27. Conway RS, Agrawal R, Betteridge DJ, Jacobs HS. Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol (Oxf) 1992;37:119-125
28. Slowińska-Srzednicka J, Zgliczyński S, Wierzbicki M, Srzednicki M, Stopińska-Gluszak U, Zgliczyński W, Soszyński P, Chotkowska E, Bednarska M, Sadowski Z. The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome. J Endocrinol Invest 1991;14:569-575
29. Raal FJ. Pathogenesis and management of the dyslipidemia of the metabolic syndrome. Metab Syndr Relat Disord 2009; 7:83-88
30. Russel JC, Amy RM, Graham S, Wenzel LM, Dolphin PJ. Effect of castration on hyperlipemic, insulin resistance JCR:LA-corpulent rats. Atheroscleroisis 1993;100:113-122
31. Wilson PW, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis 1988;8:737-741
32. Heiss G, Tamir L, Davis CE. Lipoprotein-cholesterol distributions in select North American populations: the Lipid Research Clinics Program Prevalence Study. Circulation 1980;61:302-315
33. Assmann G, Schulte H, von Eckardstein A, Huang Y. Highdensity lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 1996;124(Suppl): S11-S20
34. Monrad RN, Grunnet LG, Rasmussen EL, Malis C, Vaag A, Poulsen P. Age-dependent nongenetic influences of birth weight and adult body fat on insulin sensitivity in twins. J Clin Endocrinol Metab 2009;94:2394-2399